Tudor Investment Corp’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,429
Closed -$385K 2994
2022
Q3
$385K Sell
22,429
-105,306
-82% -$1.65M 0.01% 1592
2022
Q2
$1M Sell
127,735
-183,738
-59% -$1.58M 0.03% 883
2022
Q1
$3.45M Buy
311,473
+227,288
+270% +$2.55M 0.08% 319
2021
Q4
$1.48M Sell
84,185
-232,436
-73% -$4.51M 0.02% 792
2021
Q3
$6.41M Buy
316,621
+253,380
+401% +$6.51M 0.1% 193
2021
Q2
$2.09M Buy
63,241
+53,210
+530% +$2.01M 0.04% 544
2021
Q1
$392K Sell
10,031
-15,346
-60% -$721K 0.01% 1220
2020
Q4
$1.11M Buy
+25,377
New +$867K 0.03% 655
2020
Q3
Sell
-35,289
Closed -$1.28M 1611
2020
Q2
$1.28M Buy
+35,289
New +$994K 0.06% 401

Other funds holding ONEM

Tudor Investment Corp's ONEM Position: Q4 2022 in Review

Tudor Investment Corp sold out of 1Life Healthcare (ONEM) in Q4 2022, closing a stake of 22,429 shares — an estimated $385K sold.

Tudor Investment Corp first reported a position in ONEM in Q2 2020 and held it in 9 quarters. The position peaked at $6.41M in Q3 2021. 230 funds tracked by Wall St. Rank hold ONEM as of Q4 2022.

  • Tudor Investment Corp reported no remaining 1Life Healthcare position as of Q4 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 22,429 1Life Healthcare shares in Q4 2022, an estimated $385K.
  • Tudor Investment Corp first reported a position in 1Life Healthcare in Q2 2020 and held it in 9 quarters.
  • Tudor Investment Corp's 1Life Healthcare position peaked at $6.41M in Q3 2021.
  • 230 funds tracked by Wall St. Rank held 1Life Healthcare as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.